2022. EVALUATING THE HATCH-WAXMAN AMENDMENT’S INFLUENCE ON FDA’S GENERIC MEDICATION APPROVAL PROCESS. Journal of Pharmaceutical Negative Results. (Oct. 2022), 3393–3405. DOI:https://doi.org/10.47750/pnr.2022.13.S06.454.